Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor‐Positive, HER‐2 Negative Breast Cancer

BACKGROUND. In estrogen receptor‐positive (ER+), human epidermal growth factor receptor 2 (HER‐2) negative breast cancers, the progesterone receptor (PR) is an independent prognostic marker. Little is known about the prognostic value of PR by tumor grade. We assessed this in two independent datasets...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Van Asten, Kathleen, Slembrouck, Laurence, Olbrecht, Siel, Jongen, Lynn, Brouckaert, Olivier, Wildiers, Hans, Floris, Giuseppe, Van Limbergen, Erik, Weltens, Caroline, Smeets, Ann, Paridaens, Robert, Giobbie‐Hurder, Anita, Regan, Meredith M., Viale, Giuseppe, Thürlimann, Beat, Vergote, Ignace, Christodoulou, Evangelia, Van Calster, Ben, Neven, Patrick
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369957/
https://ncbi.nlm.nih.gov/pubmed/30171067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0176
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados